Pith. sign in

REVIEW 4 major objections 6 minor 1 cited by

Cinepro: Robust Training of Foundation Models for Cancer Detection in Prostate Ultrasound Cineloops

T0 review · 4 major / 6 minor · reviewed 2026-08-10 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Cinepro claims that a segmentation foundation model, trained with a pathology-involvement loss and a multi-frame cine-series augmentation, detects prostate cancer in ultrasound cineloops at an AUROC of 77.1% and a balanced accuracy of…

desk verdict Plausible incremental method; unstated patient-level split and a misreported balanced-accuracy metric are the key things to fix before trusting the headline numbers. read the letter →

arxiv 2501.12331 v1 pith:5VLVC6YH submitted 2025-01-21 eess.IV cs.CVcs.LGq-bio.TO

Mohamed Harmanani , Amoon Jamzad , Minh Nguyen Nhat To , Paul F.R. Wilson , Zhuoxin Guo , Fahimeh Fooladgar , Samira Sojoudi , Mahdi Gilany
show 6 more authors
Silvia Chang Peter Black Michael Leveridge Robert Siemens Purang Abolmaesumi Parvin Mousavi
This is my paper · ORCID
classification eess.IVcs.CVcs.LGq-bio.TO
keywords prostatecancerdetectionultrasoundcineloopsfoundationmodelsweaklysupervisedlearninginvolvement-awarelosstemporalaugmentationMedSAMdeep
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper claims that a segmentation foundation model can be repurposed for prostate cancer detection in ultrasound by training on the whole image rather than a small region, and by supervising it with the pathologist-reported percentage of cancer in each biopsy core rather than a binary label. The proposed framework, Cinepro, takes the first frame of a 200-frame cineloop with a light augmentation and the average of the remaining frames with heavy augmentation, shares weights between the two views, and optimizes an involvement-aware mean-squared error between the model's average activation in the needle region and the reported involvement. On a two-center dataset of 311 patients, the paper reports an AUROC of 77.1% and a balanced accuracy of 71.9%, beating prior ROI-based and whole-image baselines; the 83.8% figure quoted in the abstract is the AUROC on the subset of cores with more than 35% involvement. A sympathetic reader would care because whole-image, involvement-supervised training offers a path to better real-time biopsy guidance without pixel-level cancer annotations.

What carries the argument

The central object is the involvement-aware mean-squared error (iMSE) loss: for each core, the model's 256x256 prediction mask is averaged inside the intersection of the manually selected needle region and the prostate mask, and that scalar is forced toward the pathology-reported cancer involvement percentage. The second mechanism is a weak-strong cine-series augmentation: a lightly augmented first frame and a strongly augmented average of the other 199 frames are processed by two shared-weight encoders and combined by a confidence-thresholded weighted average before the loss is computed. Together they convert a coarse per-core label into a spatially distributed training signal.

What would settle it

Randomly permute the pathology involvement labels across cores (keeping the cancer/benign split fixed) and retrain Cinepro from the same initialization. If the AUROC remains near 77.1%, the involvement signal is not driving the gain; if it drops sharply, the label is load-bearing. A complementary check is to compute the Pearson correlation between the model's mean prediction in the needle region and the reported involvement on held-out cores, which should be substantially positive if the iMSE loss is teaching localization.

Watch

Extended reading notes

Core claim

On the paper's own terms, the central discovery is that a segmentation foundation model can be turned into a cancer detector for ultrasound without pixel-level labels by using the pathologist's per-core cancer involvement as a regression target and by training on whole cineloops with a weak-strong temporal augmentation. In a 5-fold cross-validation on two clinical centers, Cinepro reaches an AUROC of 77.1% and a balanced accuracy of 71.9%, with sensitivity of 78.1% at 60% specificity, surpassing the ROI-based iLR baseline and MaskCE/iMSE-trained UNet, SAM, and MedSAM variants. The authors report that the involvement-aware loss yields larger gains when paired with MedSAM than with UNet, and that the cine-series augmentation adds a further improvement, with the qualitative heatmaps tracking the reported 15-70% involvement range more closely than the fine-tuned MedSAM baseline. The abstract's balanced-accuracy figure of 83.8% corresponds in the results table to the AUROC on cores with more than 35% involvement, not to the table's balanced accuracy of 71.9%.

Load-bearing premise

The load-bearing premise is that the percentage of cancer measured in the extracted biopsy core corresponds to the average of what the ultrasound image shows inside the needle region, so training the model's mean activation to match that number teaches it where cancer actually is.

Editorial extensions

If this is right

  • Whole-image foundation models outperform ROI-based and patch-based approaches on this task, so keeping full anatomical context is a better default for ultrasound prostate cancer detection.
  • Using iMSE instead of masked cross-entropy improves AUROC and sensitivity at matched specificity, suggesting that involvement supervision adds information beyond a binary benign/cancer label.
  • The cine-series augmentation yields further gains on top of iMSE, and the gain is larger for a generalist SAM than for MedSAM, suggesting the strategy is most useful when pre-training is weaker.
  • At 60% specificity Cinepro reaches 78.1% sensitivity, which is the operating point the paper highlights for biopsy guidance.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • Editorial inference: The same involvement-regression loss, if it works as claimed, should transfer to other core-biopsy settings where pathology returns a proportion (e.g., tumor cellularity in breast or renal biopsy), provided the needle track is visible.
  • Editorial inference: Because the loss averages over a 2D needle region while the pathology core spans 18 mm of tissue, a volumetric ultrasound formulation would be a stricter test of whether the involvement signal or the temporal averaging is doing the heavy lifting.
  • Editorial inference: An ablation using fewer than 199 averaged frames would reveal whether the cine-series gain comes from denoising per se or from the particular temporal statistics of 3-5 seconds of transducer motion.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 6 minor

Summary. This manuscript presents Cinepro, a training framework that adapts the MedSAM segmentation foundation model to prostate cancer detection in B-mode ultrasound cineloops. The method uses an 'involvement-aware' MSE loss that penalizes the difference between the mean model activation over the biopsy needle region and the pathologically reported percentage of cancer in the corresponding core, and a weak-strong augmentation scheme that combines a single frame with an averaged multi-frame 'strong' augmentation. The authors evaluate Cinepro against several in-house baselines (ROI-based iLR, UNet/SAM/MedSAM with masked CE or iMSE losses, with and without weak-strong augmentation) using 5-fold cross-validation on a private two-center dataset of 311 patients, reporting an AUROC of 77.1% and claiming superior performance over the baselines.

Significance. The idea of using quantitative pathology involvement as a regression target for a segmentation foundation model is a thoughtful approach to weak label noise, and the cine-series augmentation is a sensible use of temporal ultrasound data. The paper compares against a reasonable set of baselines and provides qualitative heatmaps. If the reported improvements are reliable, the approach would be a useful contribution to foundation-model fine-tuning for ultrasound. However, the present version contains internal numerical inconsistencies and an under-specified evaluation protocol, so the significance of the empirical claim is currently uncertain.

major comments (4)
  1. [Abstract and Section 3 (Results, first and last paragraphs)] The abstract reports a balanced accuracy of 83.8%, and Section 3 states that Cinepro improves AUROC and balanced accuracy by +1.9% and +2.3% over the strongest baseline. According to Table 2, Cinepro's balanced accuracy is 71.9±1.6, not 83.8; the value 83.8 is the AUROC on the inv>0.35 subset. Also, compared with the strongest baseline (MedSAM+iMSE+WS-Augs), the improvements are +1.0 AUROC and +1.0 balanced accuracy, not +1.9/+2.3. These numbers must be corrected and the claims restated to match the table.
  2. [Section 2.4 (Experiments)] The 5-fold cross-validation is described only as 'all models are trained and evaluated using a 5-fold cross-validation scheme.' The split unit is not stated. Since each patient contributes 10–12 cores (Section 2.1), a core-level split would put multiple cores from the same patient in both training and test, allowing patient-specific or transducer-specific cues to inflate performance. The paper must specify whether the folds are patient-level or core-level, and if the latter, justify why this does not constitute leakage.
  3. [Section 2.2, Eq. (1)] The loss function as written is mathematically inconsistent with the described behavior. The equation sums over all i,j ∈ [0,1024] the squared term (Ŷ[i,j]·1_{Ŷ[i,j]∈R} − inv)². For pixels outside R, the indicator makes the first term zero, so the contribution is inv², which would dominate the loss over the more than one million background pixels. The intended loss should be the mean of (Ŷ[i,j] − inv)² over pixels in R, e.g., using an indicator outside the square (or a sum restricted to R). Please correct the formula and confirm the implementation matches the intended definition.
  4. [Section 2.2 (Involvement-aware training)] The iMSE loss is built on the assumption that the pathologically reported proportion of cancer in a biopsy core equals the spatial average of the model's pixel-level predictions over the needle region in the 2D ultrasound image. This assumption requires that the spatial distribution of cancer in the extracted core is faithfully represented in the 2D image plane, which is not self-evident given tissue deformation, needle placement, and slice thickness. The paper should acknowledge this assumption and provide supporting evidence (e.g., a scatter plot of predicted mean activation vs. reported involvement across cores) to justify the loss form.
minor comments (6)
  1. [Section 2.2, first paragraph] The text says 'we select the pixels in the needle region' for the final prediction, but the loss function defines R as the intersection of the needle region with the prostate mask. Please clarify which region is used for scoring and for the loss.
  2. [Section 2.2, Eq. (1)] The index ranges are inconsistent (text says i,j∈[1,1024] but the sum is written from 0 to 1024); please fix.
  3. [Section 2.3] The sentence 'The apply a confidence threshold, τ, to the output fθ(Xw)' contains a typo; it should be 'They apply' or 'We apply'.
  4. [Section 2.3] The hyperparameters τ, γ_w, and γ_s are described as tunable but their values or tuning procedure are not given; please provide them in the paper (or an appendix) rather than only in the GitHub repository.
  5. [Section 3 (Results)] The claim that dual-augmented versions 'outperform their base counterparts ... by 6% and 1.1%' is ambiguous; specify whether these are absolute or relative differences and which metric is being referenced.
  6. [Section 2.1 (Preprocessing)] The exclusion of data containing motion and acoustic shadowing artifacts is mentioned but the number of excluded cineloops/cores is not reported; please quantify to allow assessment of selection bias.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: supervised training and held-out evaluation; reporting inconsistencies are correctness, not circularity.

full rationale

The paper's core mechanism is a supervised training objective, not a derivation: the iMSE loss (Section 2.2) minimizes the squared difference between the mean predicted activation over the needle region and the pathology-reported cancer involvement, and the model is evaluated on held-out folds of the same multi-center dataset with pathology labels as ground truth. No fitted constant or training-set aggregate is renamed as a prediction, and no uniqueness theorem or load-bearing result is imported from the authors' prior work. The self-citations ([2], [3], [10]) provide baselines and clinical context, but the central comparison in Table 2 is an empirical head-to-head over the same folds, so these citations are not the argument's load-bearing support. The abstract's 'balanced accuracy of 83.8%' conflicts with the 71.9% ± 1.6 value in Table 2 (83.8% appears to be the AUROC on the inv>0.35 subset), and Section 2.4 does not state whether the 5-fold split is by patient or by core; these are reporting and validity concerns, not circularity. The iMSE objective directly supervises the model with involvement labels, but that is standard supervised learning on held-out data rather than a self-referential reduction.

Assumptions & free parameters 2 free parameters · 4 assumptions · 0 invented entities

The central claim rests on several domain assumptions about the correspondence between coarse pathology labels and ultrasound image content, plus standard transfer-learning assumptions. No renormalization or hidden fitted constants beyond the unreported hyperparameters.

free parameters (2)
  • tau (confidence threshold)
    Hyperparameter in the cine-series augmentation (Section 2.3), tuned on validation folds but not reported in the paper.
  • gamma_w and gamma_s (weighted average weights)
    Tunable hyperparameters with gamma_w + gamma_s = 1 (Section 2.3), values not reported in the paper.
assumptions (4)
  • domain assumption Pixel-level cancer presence in ultrasound can be approximated by core-level pathology involvement proportion.
    The iMSE loss (Section 2.2) forces the mean model activation over the needle region to equal the pathology-reported involvement. This assumes spatial correspondence between the 2D ultrasound needle region and the 3D biopsy core.
  • domain assumption The manually selected needle region and prostate mask are accurate.
    Section 2.1 and 2.2 rely on manual selection of the biopsy needle region and a prostate mask P; errors in these regions propagate to the loss.
  • domain assumption MedSAM's pre-trained representations transfer to ultrasound cancer detection.
    The method uses MedSAM weights without modification, assuming that pre-training on natural and medical images provides useful features for ultrasound texture analysis.
  • domain assumption RF-to-B-mode conversion preserves cancer-relevant information.
    Preprocessing converts raw RF data to B-Mode images; the method trains only on B-Mode.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Cinepro: Robust Training of Foundation Models for Cancer Detection in Prostate Ultrasound Cineloops." pith.science (2026). https://pith.science/paper/5VLVC6YH

@misc{pith2026250112331,
  author       = {Pith},
  title        = {Pith review of: Cinepro: Robust Training of Foundation Models for Cancer Detection in Prostate Ultrasound Cineloops},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/5VLVC6YH}},
  note         = {Machine review of arXiv:2501.12331}
}
read the original abstract

Prostate cancer (PCa) detection using deep learning (DL) models has shown potential for enhancing real-time guidance during biopsies. However, prostate ultrasound images lack pixel-level cancer annotations, introducing label noise. Current approaches often focus on limited regions of interest (ROIs), disregarding anatomical context necessary for accurate diagnosis. Foundation models can overcome this limitation by analyzing entire images to capture global spatial relationships; however, they still encounter challenges stemming from the weak labels associated with coarse pathology annotations in ultrasound data. We introduce Cinepro, a novel framework that strengthens foundation models' ability to localize PCa in ultrasound cineloops. Cinepro adapts robust training by integrating the proportion of cancer tissue reported by pathology in a biopsy core into its loss function to address label noise, providing a more nuanced supervision. Additionally, it leverages temporal data across multiple frames to apply robust augmentations, enhancing the model's ability to learn stable cancer-related features. Cinepro demonstrates superior performance on a multi-center prostate ultrasound dataset, achieving an AUROC of 77.1% and a balanced accuracy of 83.8%, surpassing current benchmarks. These findings underscore Cinepro's promise in advancing foundation models for weakly labeled ultrasound data.

Figures

Figures reproduced from arXiv: 2501.12331 by the authors.

Figure 1
Figure 1. The architecture consists of a vision transformer [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. Ultrasound Image Generation using Latent Diffusion Models

    cs.CV 2025-02 conditional novelty 4.0 of 10

    Fine-tuning Stable Diffusion on breast ultrasound images can generate realistic synthetic ultrasound images, and conditioning with segmentation masks via ControlNet gives user control over lesion shape.

Reference graph

Works this paper leans on

18 extracted references · 17 canonical work pages · cited by 1 Pith paper

  1. [1]

    INTRODUCTION Early detection of prostate cancer (PCa) is crucial to improve patient outcomes and reduce the risk of mortality. PCa detec- tion is performed using systematic biopsy under the guidance of trans-rectal ultrasound (TRUS), by sampling 8-12 pre- defined anatomical locations of the prostate, followed by histopathological analysis of the cores. Th...

    arXiv 2025

  2. [2]

    MA TERIALS AND METHODS 2.1. Data Acquisition: We use private data from 311 patients in two clinical centers: Kingston Health Sciences Center (KHSC) in Ontario and Vancouver General Hospital (VGH) in British Columbia, Canada (Table 1). The study was approved by the institutional health research ethics boards and all patients provided informed verbal and wr...

    work page 1960

  3. [3]

    We observe that whole-image methods outperform the iLR baseline considerably, highlighting their advantage over ROI methods

    RESULTS Quantitative results: Our experimental results are shown in Table 2. We observe that whole-image methods outperform the iLR baseline considerably, highlighting their advantage over ROI methods. Moreover, foundation models exceed other baselines in performance, with MedSAM and SAM consistently outperforming UNet across most metrics. Our proposed lo...

    work page

  4. [4]

    CONCLUSION We proposed Cinepro, a novel adaptation of segmentation- based foundation models to prostate cancer classification from ultrasound. We further introduced a robust framework for fine-tuning foundation models on weakly labeled prostate ultrasound data, using a involvement-driven loss function to 4 increase the model’s robustness to noise through ...

    work page

  5. [5]

    COMPLIANCE WITH ETHICAL STANDARDS This study was approved by the Institutional Research Ethics Board at both sites, and patients provided informed consent to participate

    work page

  6. [6]

    Parvin Mousavi is supported by the CIFAR AI Chair and the Vector Institute

    ACKNOWLEDGEMENTS This work was supported by the Natural Sciences and Engi- neering Research Council of Canada (NSERC), and the Cana- dian Institutes of Health Research (CIHR). Parvin Mousavi is supported by the CIFAR AI Chair and the Vector Institute. None of the other authors have potential conflicts of interest to disclose

    work page

  7. [7]

    & Emberton, M

    Ahmed, H., Bosaily, A., Brown, L., Gabe, R., Kaplan, R., Parmar, M., Collaco-Moraes, Y ., Ward, K., Hindley, R., Freeman, A., Kirkham, A., Oldroyd, R., Parker, C. & Emberton, M. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet. 389, 815-822 (2017)

    work page 2017

  8. [8]

    & Mousavi, P

    Wilson, P., Harmanani, M., To, M., Gilany, M., Jamzad, A., Fooladgar, F., Wodlinger, B., Abolmaesumi, P. & Mousavi, P. Toward confident prostate cancer detection using ultrasound: a multi-center study. International Journal Of Computer Assisted Radiology And Surgery . pp. 1-9 (2024)

    work page 2024

Show all 18 references
  1. [9]

    & Mousavi, P

    Wilson, P., To, M., Jamzad, A., Gilany, M., Harmanani, M., Elghareb, T., Fooladgar, F., Wodlinger, B., Abol- maesumi, P. & Mousavi, P. ProstNFound: Integrating Foundation Models with Ultrasound Domain Knowl- edge and Clinical Context for Robust Prostate Cancer Detection. Inter...

    2024

  2. [10]

    & Wang, B

    Ma, J., He, Y ., Li, F., Han, L., You, C. & Wang, B. Segment anything in medical images.Nature Communi- cations. 15, 654 (2024)

    2024

  3. [11]

    Segment anything

    Kirillov, A., Mintun, E., Ravi, N., Mao, H., Rolland, C., Gustafson, L., Xiao, T., Whitehead, S., Berg, A., Lo, W., et al. Segment anything. Proceedings Of The IEEE/CVF International Conference On Computer Vi- sion. pp. 4015-4026 (2023)

    2023

  4. [12]

    & Feleppa, E

    Rohrbach, D., Wodlinger, B., Wen, J., Mamou, J. & Feleppa, E. High-frequency quantitative ultrasound for imaging pca using a novel micro-us scanner.Ultrasound In Medicine And Biology. 44, 1341-1354 (2018)

    2018

  5. [13]

    Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

    Bulten, W., Kartasalo, K., Chen, P., Str¨om, P., Pinckaers, H., Nagpal, K., Cai, Y ., Steiner, D., Boven, H., Vink, R., et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Na- ture Medicine. 28, 154-163 (2022)

    2022

  6. [14]

    Sohn, K., Berthelot, D., Carlini, N., Zhang, Z., Zhang, H., Raffel, C., Cubuk, E., Kurakin, A. & Li, C. Fix- match: Simplifying semi-supervised learning with con- sistency and confidence. Advances In Neural Informa- tion Processing Systems. 33 pp. 596-608 (2020)

    2020

  7. [15]

    & Shi, Y

    Yang, L., Qi, L., Feng, L., Zhang, W. & Shi, Y . Re- visiting weak-to-strong consistency in semi-supervised semantic segmentation. Proceedings Of The IEEE/CVF Conference On Computer Vision And Pattern Recogni- tion. pp. 7236-7246 (2023)

    2023

  8. [16]

    & Abolmaesumi, P

    To, M., Fooladgar, F., Javadi, G., Bayat, S., Sojoudi, S., Hurtado, A., Chang, S., Black, P., Mousavi, P. & Abolmaesumi, P. Coarse label refinement for improving prostate cancer detection in ultrasound imaging. Inter- national Journal Of Computer Assisted Radiology And Surgery...

    2022

  9. [17]

    & Chen, T

    Huang, T., Lu, N., Huang, Y ., Twan, W., Yeh, L., Liu, K. & Chen, T. Transfer learning with CNNs for efficient prostate cancer and BPH detection in transrectal ultra- sound images. Scientific Reports. 13, 21849 (2023)

    2023

  10. [18]

    MicroSegNet: A deep learning approach for prostate segmentation on micro-ultrasound images

    Jiang, H., Imran, M., Muralidharan, P., Patel, A., Pensa, J., Liang, M., Benidir, T., Grajo, J., Joseph, J., Terry, R., et al. MicroSegNet: A deep learning approach for prostate segmentation on micro-ultrasound images. Computerized Medical Imaging And Graphics . 112 pp. 102326...

    2024

Pith tools

Reviewed August 10, 2026 · model on record in the stance chip above.